Wenxiao Zheng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Dna Damage Response

Top Venues

Antiviral chemistry & chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Wenxiao Zheng, Leonardo D'Aiuto, Matthew J Demers, Vaishali Muralidaran, Joel A Wood, Maribeth Wesesky, Ansuman Chattopadhyay, Vishwajit L Nimgaonkar
Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs. Antiviral chemistry & chemotherapy 29 (2021)